Northwest Biotherapeutics Company
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Headquarters:
Bethesda, Maryland, United States
Total Funding:
169400000
Last Funding Type:
Post-IPO Debt
Founded Date:
1998-01-01
Estimated Revenue:
Less than $1M
Industry:
Dendritic Cells
Last Funding Date:
2021-11-22
Funding Status:
IPO
Investors Number:
1
Employee Number:
11-50